Get startedLog in
    Picture of ONO PHARMACEUTICAL logo

    4528 — ONO PHARMACEUTICAL News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeLarge CapSuper Stock
    All News

    Brief: Ono Pharmaceutical says collaboration with Fate Therapeutics for two iPSC-derived CAR-T Therapies for Cancers

    Picture of ONO PHARMACEUTICAL logoONO PHARMACEUTICAL
    18/09/2018 01:24
    Sept 18(Reuters) - Ono Pharmaceutical Co Ltd  4528.T  
    
    * Says it entered into a collaboration agreement with Fate
Therapeutics Inc  FATE.O , for the joint development and
commercialization of two off-the-shelf chimeric antigen
receptor(CAR)-T cell product candidates for cancer

    
    
    Source text in Japanese:https://goo.gl/KXnHpn
    Further company coverage: 4528.T  FATE.O 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))

    Recent news on ONO PHARMACEUTICAL

    See all news